Cardiac Transplantaion in Patients with Refractory Ventricular Arrhythmias

Journal of Heart and Lung Transplantation

Volumn 19, Issue 8, 2000, Pages

  Olivari, Maria Teresa ^a   Windle, John R ^b  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMORBIDITY; CONGESTIVE HEART FAILURE; HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEMODYNAMICS; HUMAN; LUNG VASCULAR RESISTANCE; PRIORITY JOURNAL; REVIEW;

FEMALE; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; MALE; PROGNOSIS; SURVIVAL RATE; TREATMENT FAILURE; VENTRICULAR FIBRILLATION;

EID: 0034632642     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1053-2498(99)00105-9     Document Type: Article

References (37)

1. Mudge GH, Goldstein S, Addonizio LJ, et al. Task Force 3: Recipient Guidelines/Prioritization. 24th Bethesda Conference: Cardiac Transplantation. J Am Coll Cardiol 1993;22: 21-31.
2. Costanzo MR, Augustine S, Bourge R, et al. Selection and treatment of candidates for heart transplantation: a statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 1995;92:3592-612.
3. Meinertz T, Hofman T, Kasper W. Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 1984;53:902-7.
4. DeMaria R, Gavazzi A, Caroli A, Ometto R, Biagini A, Camerini F on behalf of the Italian Multicenter Cardiomyopathy Study (SPIC) Group. Ventricular arrhythmias in dilated cardiomyopathy as an independent prognostic hallmark. Am J Cardiol 1992;69:1451-7.
5. Dorral HC, Nul DR, Grancelli HO, et al for the GESICA- GEMA Investigators. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. Circulation 1996;94:3198-203.
6. United Network Organ Sharing (UNOS) guidelines for cardiac transplantation listing. 1. Current indications for transplant listing. C. Life-threatening refractory ventricular arrhythmia patients. 1996:31.
7. Lemery R, Brugada P, Della Bella P, Dugernier T, van den Dool A, Wellens HJJ. Nonischemic ventricular tachycardia. Clinical course and long-term follow-up in patients without clinically overt heart disease. Circulation 1989;79:990-9.
8. Dean JW, Lab MJ. Arrhythmia in heart failure: role of mechanically induced changes in electrophysiology. Lancet 1989;1:1309-12.
9. The Cardiac Arrhythmias Suppression Trial (CAST) Investigation. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321: 406-10.
10. Nicklas JM, McKenna WJ, Stewart RA, et al. Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy. Am Heart J 1991;122:1016-21.
11. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R. Randomized trial of low-dose amiodarone in severe congestive heart failure. Lancet 1994;344:493-8.
12. Stevenson WG, Stevenson LW, Middlekauff HR, et al. Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. J Am Coll Cardiol 1995; 26:1417-23.
13. Fletcher RD, Cintron GB, Johnson G, Orndorff J, Carson P, Cohn JN for the V-HeFT II VA Cooperative Studies Group. Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. Circulation 1993;87(suppl VI):VI49-55.
14. Fonarow GC, Chelimski-Fallick C, Stevenson LW, et al. Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: The Hy-C trial. J Am Coll Cardiol 1992;19:842-50.
15. Fletcher RD, Cintron GB, Johnson G, et al. Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. Circulation 1993: 87(suppl VI):VI-49-55.
16. Kugler JD, Pinsky WW, Cheatham JP, Hofschire PF, Fleming WH. Sustained ventricular tachycardia after repair of tetralogy of Fallot: new electrophysiologic findings. Am J Cardiol 1983;51:1137-43.
17. Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med 1987;316:780-9, 884-52.
18. Moolman JC, Corfield VA, Posen B, et al. Sudden death due to troponin T mutations. J Am Coll Cardiol 1997;29:549-55.
19. Kligfield P, Levy D, Devereux RB, Savage DD. Arrhythmias and sudden death in mitral valve prolapse. Am Heart J 1987;113:1298-1307.
20. Kligfield P, Hochreiter C, Kramer H, et al. Complex arrhythmias in mitral regurgitation with and without mitral valve prolapse: contrast to arrhythmias in mitral valve prolapse without mitral regurgitation. Am J Cardiol 1985;55: 1545-9.
21. Dunnigan A, Staley NA, Smith SA, et al. Cardiac and skeletal muscle abnormalities in cardiomyopathy: comparison of patients with ventricular tachycardia or congestive heart failure. J Am Coll Cardiol 1987;10:608-18.
22. Mallat Z, Tedgui A, Fontaliran F, Frank R, Durigon M, Fontaine G. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 1996;335:1190-6.
23. Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation 1996;94:983-91.
24. Rampazzo A, Nava A, Danieli GA, et al. The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. Hum Mol Genet 1994;3:959-62.
25. Mehta D, Goldman M, David O, Gomes JA. Value of quantitative measurement of signal-averaged electrocardiographic variables in arrhythmogenic right ventricular dysplasia: correlation with echocardiographic right ventricular cavity dimensions. J Am Coll Cardiol 1996;28:713-9.
26. Moss AJ, Hall J, Cannom DS, et al for the Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-40.
27. Fogoros RN, Elson JJ, Bonnet CA, Fiedler SB, Burkholder JA. Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease. J Am Coll Cardiol 1990;16:381-6.
28. Tchou PJ, Kadri N, Anderson J, Caceres JA, Jazayeri M, Akhtar M. Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias. Ann Inter Med 1988;109: 529-34.
29. Sweeney MO, Ruskin JN. Current perspectives: mortality benefits and the implantable cardioverter-defibrillator. Circulation 1994;89:1851-8.
30. Hosenpud JD, Norrick RJ, Breen TJ, Keck B, Daily P. The Registry of the International Society for Heart and Lung Transplantation: twelfth official report - 1995. J Heart Lung Transplant 1995;41:805-15.
31. Gonska B-D, Cao K, Raab J, Eigster G, Kreuzer H. Radiofrequency catheter ablation of right ventricular tachycardia late after repair of congenital heart defects. Circulation 1996;94:1902-8.
32. Klein LS, Shih H-T, Hackett FK, Zipes DP, Miles WM. Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease. Circulation 1992; 1666-74.
33. Meredith JT, Broughton A, Jennings GL, Esler MD. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 1991;325:618-24.
34. Vantrimpont P, Rouleau JL, Wun C-C, et al for the SAVE investigators. Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the survival and ventricular enlargement (SAVE) study. J Am Coll Cardiol 1997;29:229-36.
35. Kelly P, Ruskin JN, Vlahakes GJ, Buckley MJ, Freeman CS, Garan H. Surgical coronary revascularization in survivors of prehospital cardiac arrest: its effect on inducible ventricular arrhythmias and long-term survival. J Am Coll Cardiol 1990;15:267-73.
36. Olivari MT. Cardiac transplantation: current indications, short- and long-term results, economic implications, and future developments. J Card Fail 1996;2:141-52.
37. Bourge RC, Naftel DC, Costanzo-Nordin MR et al for the Transplant Cardiologists Research Database Group. Pre- transplantation risk factors for death after heart transplantation: a multi-institutional study. J Heart Lung Transplant 1993;12:549-62.